Cannabis Control Commission Appeals Ruling Halting License Rollout
The 2026 cannabis license rollout appeal underscores ongoing regulatory challenges impacting patient access to tested cannabis products. Legal disputes delay new license issuance, affecting market maturation. Patients and providers face uncertainty…
Cannabis Applicants Criticize State Over Slow Licensing Process
2026 cannabis licensing delays are causing significant challenges for patient access to regulated cannabis products. These regulatory bottlenecks impact clinical practice by limiting availability of quality-assured therapeutics. Understanding these…
Cannabis license rollout halted as federal judge blocks enforcement of RI’s residency requirement
✦ New CED Clinical Relevance #82High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic PolicyRegulationPatient AccessSupply…
